购物车
您的购物车当前为空
Envometinib (Compound B) 是双MEK抑制剂,利用深度循环抑制 (DCI) 起作用。在各种体内模型中,Envometinib 显示出抗肿瘤活性,并可用于研究RAS和RAF突变的癌症,如结直肠癌和黑色素瘤。

Envometinib (Compound B) 是双MEK抑制剂,利用深度循环抑制 (DCI) 起作用。在各种体内模型中,Envometinib 显示出抗肿瘤活性,并可用于研究RAS和RAF突变的癌症,如结直肠癌和黑色素瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | Envometinib (Compound B) is a dual MEK inhibitor that operates through deep cyclic inhibition (DCI). It exhibits antitumor activity across various in vivo models and is applicable in researching RAS and RAF mutated cancers, such as colorectal cancer and melanoma. |
| 分子量 | 523.00 |
| 分子式 | C23H27ClN4O6S |
| CAS No. | 2952542-22-0 |
| Smiles | O=C1OC=2C=C(OC(=O)N(C)C)C=CC2C(=C1CC=3C=CC=C(NS(=O)(=O)NC)C3Cl)CN(C)C |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.(实际储存温度请以该批次产品标识为准) |
对于不同动物的给药剂量换算,您也可以参考 更多